Drug Re-purposing from SARS-CoV Led the Identification of Potential Candidate Drug Target and Alternate Drug Molecules Against SARSCoV- 2

Author(s): PV Parvati Sai Arun*, Razak Hussain, Yusuf Akhter, Mandava Venkata Basaveswara Rao, Perugu Shyam, Sailu Yellaboina

Journal Name: Letters in Drug Design & Discovery

Volume 17 , Issue 10 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: SARS-CoV-2 causes COVID19 disease where there are no suitable drugs available.

Objective: The objective of the work is to repurpose the drugs prescribed for SARS-CoV as the drugs for the control of SARS-CoV-2.

Methods: In this work, we have used homology searches and docking methods for understanding the mechanism of the drugs prescribed for the control of SARS-CoV on SARS-CoV-2.

Results: In our analysis, we found that the drugs Benzyl (2-Oxopropyl)carbamate, 2-[(2,4-Dichloro- 5-methyl phenyl)sulfonyl]-1,3-dinitro-5-(trifluoromethyl)benzene, S-[5-(Trifluoromethyl)-4H-1,2,4- triazol-3-YL] 5-(phenylethynyl)furan-2-carbothioate, 4-(Dimethylamino)benzoic acid, which are capable of inhibition of the activity of 3CLPro and prevent the progression of SARS-CoV.

Conclusion: In this letter, we describe the findings of the protein ligand interactions between 3CLPro of SARS-CoV, SARS-CoV-2 with Benzyl (2-oxopropyl) carbamate.

Keywords: Drugs, repurposing, SARS-CoV, SARS-CoV-2, 3CLpro, Benzyl(2-oxopropyl) carbamate.

Baden, L.R.; Rubin, E.J. Covid-19-The Search for Effective Therapy; Mass Medical Soc, 2020.
Gautret, P.; Lagier, J-C.; Parola, P.; Hoang, V.T.; Meddeb, L.; Mailhe, M.; Doudier, B.; Courjon, J.; Giordanengo, V.; Vieira, V.E.; Dupont, H.T.; Honoré, S.; Colson, P.; Chabrière, E.; La Scola, B.; Rolain, J.M.; Brouqui, P.; Raoult, D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open label non-randomized clinical trial. Int. J. Antimicrob. Agents, 2020, 56(1), 105949.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105949] [PMID: 32205204]
Munster, V.J.; Koopmans, M.; van Doremalen, N.; van Riel, D.; de Wit, E. A novel coronavirus emerging in China-key questions for impact assessment. N. Engl. J. Med., 2020, 382(8), 692-694.
[http://dx.doi.org/10.1056/NEJMp2000929] [PMID: 31978293]
Zhou, P.; Yang, X-L.; Wang, X-G.; Hu, B.; Zhang, L.; Zhang, W. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv, 2020, 1(22), 914952.
Perlman, S. Another decade, another coronavirus. New. Engl. J. Med., 2020, 382(8)
[http://dx.doi.org/ 10.1056/NEJMe2001126] [http://dx.doi.org/10.1056/NEJMe2001126]
Bacha, U.; Barrila, J.; Gabelli, S.B.; Kiso, Y.; Mario Amzel, L.; Freire, E. Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro). Chem. Biol. Drug Des., 2008, 72(1), 34-49.
[http://dx.doi.org/10.1111/j.1747-0285.2008.00679.x] [PMID: 18611220]

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 11 October, 2020
Page: [1325 - 1327]
Pages: 3
DOI: 10.2174/1570180817999200730190600

Article Metrics

PDF: 20